Wealth Enhancement Advisory Services, LLC Alkermes Plc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 16,107 shares of ALKS stock, worth $531,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,107
Previous 10,189
58.08%
Holding current value
$531,853
Previous $293,000
58.02%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALKS
# of Institutions
375Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$961 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$611 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$405 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$291 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$250 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.42B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...